Clinical Trial Update: N-Acetylcysteine and Smoking Reduction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating N-acetylcysteine for smoking reduction in nicotine dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED